Assignee profile:

AbbVie Inc.

City:

Abbott Park, Illinois

Country:

United States

Published Applications:

14

Last publication date:

2014-11-13

Patent Grants:

12

Last grant date:

2016-11-15

Top Inventors for applications by AbbVie Inc.

These are the the leading inventors for applications assigned to AbbVie Inc.:

Recent patent applications by AbbVie Inc.

AbbVie Inc. based in Abbott Park, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2014-11-13
US20140335014A1
Chemistry; metallurgy

IL-1 ALPHA DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND USES THEREOF

#2 | 2014-09-25 ✅ Patent 9,493,506 granted on 2016-11-15
US20140287992A1
Chemistry; metallurgy

Macrocyclic hepatitis C serine protease inhibitors

#3 | 2014-08-07 ✅ Patent 9,447,184 granted on 2016-09-20
US20140220020A1
Chemistry; metallurgy

IL-1 binding proteins

#4 | 2014-07-31 ✅ Patent 9,441,038 granted on 2016-09-13
US20140212925A1
Chemistry; metallurgy

IL-1 binding proteins

#5 | 2014-07-31 ✅ Patent 9,447,183 granted on 2016-09-20
US20140212379A1
Chemistry; metallurgy

IL-1 binding proteins

#6 | 2014-07-24 ✅ Patent 9,409,986 granted on 2016-08-09
US20140205562A1
Chemistry; metallurgy

IL-1 binding proteins

#7 | 2014-06-26 ✅ Patent 9,670,276 granted on 2017-06-06
US20140178389A1
Chemistry; metallurgy

IL-1 binding proteins

#8 | 2014-05-29 ✅ Patent 9,309,279 granted on 2016-04-12
US20140148573A1
Chemistry; metallurgy

Macrocyclic hepatitis C serine protease inhibitors

#9 | 2014-04-10 ✅ Patent 9,303,085 granted on 2016-04-05
US20140099671A1
Chemistry; metallurgy

IL-1 binding proteins

#10 | 2013-08-29 ✅ Patent 9,255,074 granted on 2016-02-09
US20130224149A1
Chemistry; metallurgy

Process for preparing antiviral compounds

#11 | 2013-07-11 ✅ Patent 9,346,785 granted on 2016-05-24
US20130178630A1
Chemistry; metallurgy

Process for making HCV protease inhibitors

#12 | 2013-05-30 ✅ Patent 8,592,589 granted on 2013-11-26
US20130136804A1
Human necessities

Methods of treating cancer with a thieno[3,2-C]pyridine

#13 | 2013-05-16
US20130123317A1
Human necessities

2-((R)-2-METHYLPYRROLIDIN-2-YL)-1H-BENZIMIDAZOLE-4-CARBOXAMIDE CRYSTALLINE FORM 1

#14 | 2013-02-14 ✅ Patent 9,181,275 granted on 2015-11-10
US20130040940A1
Chemistry; metallurgy

Mercaptoamidine derivatives and methods of use

Also check out AbbVie Inc.'s (Abbott Park, United States) applicant profile with 7 patent applications submitted.

AssigneeID:

9579 ⎘